Injury risk detection and recommendation platform to support LFC’s Men’s, Women’s, and Under-23 teams – with mission to keep athletes in peak condition
PALO ALTO, Calif., May 18, 2022 /PRNewswire/ — Zone7, the AI-driven human performance platform is expanding its service to Liverpool Football Club (“Liverpool FC”), a leading professional football club in the English Premier League, for a further two years and will cover the men’s, women’s and Under 23 teams.
Liverpool FC has been using Zone7’s technology since the start of the 2021/2022 season. The platform analyzes comprehensive player information, including in-game and training data, as well as biometric, strength, sleep, and stress levels to create injury risk signals and practical intervention methods that aim to improve athlete performance while lowering injury incident rates.
“Zone7 has been a helpful resource over the last nine months, supporting our internal load monitoring systems to help optimise the level of care that the Fitness and Medical Team provides to each player on a daily basis,” said Conall Murtagh, First-Team Fitness Coach for Liverpool FC.
“The platform’s innovative features, underpinned by artificial intelligence, have the ability to harness all forms of athlete performance data. It is a very exciting development for the future load management of elite football players. We look forward to the service expanding to cover our women’s and under 23 teams.”
Tal Brown, Co-Founder and CEO of Zone7, added: “We are delighted and humbled to continue our work alongside Liverpool FC’s world class fitness, medical and data operators. The Club has been a true pioneer in data science adoption across several functions.”
Liverpool FC is one of England’s most successful clubs, both currently and historically. In recent years, the men’s first team has won the EFL’s Carabao Cup (2022), its first Premier League title (2020), the FIFA Club World Cup (2019), as well as its sixth European Cup (2019). For several reasons, the men’s first team has seen a reduction in non-contact injuries compared to the previous seasons.
Zone7 has helped other leading football (soccer) teams reduce injury incidence rates by as much as 50%. In the last 12 months, the Company has also onboarded new adopters across La Liga, the National Football League (NFL), and the National Basketball Association (NBA).
About Zone7
Zone7 is a proprietary artificial intelligence platform committed to helping sporting organizations mitigate athlete injury risk and keep players on the field. By analyzing disparate datasets, the technology detects patterns, uncovers insights, and makes proactive training recommendations that optimize for athlete performance and injury prevention. Founded in 2017 by CEO Tal Brown and CTO Eyal Eliakim, Zone7 has logged more than 200 million hours of athletic action, and is used by professional teams across the EPL, MLS, NFL, La Liga, Serie A, and professional rugby. The company is headquartered in Palo Alto, CA, with offices in Tel Aviv and London. For more information, please visit Zone7.ai, or follow Zone7 on Twitter and LinkedIn.
Contact
Aidan O’Connor
Zone7
aidan@zone7.ai
View original content to download multimedia:https://www.prnewswire.com/news-releases/zone7-expands-service-to-liverpool-fc-301549906.html
SOURCE Zone7
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…